Dražan Butorac

Dražan Butorac

Auto-generated profile, based on publicly available information

Dražan Butorac

Department of Obstetrics and Gynecology, Sestre Milosrdnice University Hospital Center, 10000 Zagreb, Croatia

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2025 in Acta Pharmaceutica
Verified
Journal Article
Open access
PDF file
ABAdriana Bokulić
Adriana Bokulić
DBDražan Butorac
Dražan Butorac
IDIvka Djaković
Ivka Djaković
MČMarijo Čukelj
Marijo Čukelj
MRMarija Grdić Rajković
Marija Grdić Rajković
Preeclampsia (PE) is a complex pregnancy disorder that may cause adverse outcomes for mother and baby. Combining risk factors with clinical, laboratory, and ultrasonographic data can help identify women at risk. This study investigated the relationship between maternal risk factors, soluble fms-like tyro-sine kinase 1 (sFlt-1), placental growth factor (PlGF), their ratio, and pregnancy outcomes, involving 68 women with PE risk factors and 21 controls. There were no significant differences in the frequency of adverse outcomes (PE, foetal death, and infants with abnormal birth weight), sFlt-1, PlGF, the sFlt-1/PlGF ratio, or birth weight centiles between the PE-risk and control groups. The most frequently recorded high-risk factor was gestational diabetes mellitus, whereas moderate risk was a pre-pregnancy body mass index of over 30 kg m –2 . The most prominent difference was observed in the subgroups with gestational hypertension and first-time pregnant women as risk factors, with significantly higher sFlt-1/PlGF ratios compared to the control group. Combining multiple risk factors increased the sFlt-1/PlGF ratio compared to both the control group and the group with only one risk factor. The study documented PE risk factors and outcomes at a Croatian hospital where angiogenic markers are not routinely used in screening. Findings highlighted the importance of integrating PE screening into standard practice.

21 May 2026 in Clinical and Experimental Obstetrics & Gynecology
Verified
Journal Article
Open access
PDF file
ABAdriana Bokulić
Adriana Bokulić
DBDražan Butorac
Dražan Butorac
IDIvka Djaković
Ivka Djaković
MČMarijo Čukelj
Marijo Čukelj
SSSandra Stasenko
Sandra Stasenko
MRMarija Grdić Rajković
Marija Grdić Rajković
Background: Hypertensive disorders in pregnancy, such as gestational hypertension (GH), pose significant risks to maternal and fetal health, affecting a substantial proportion of pregnancies worldwide. Despite their prevalence, the dynamics of various biomarkers across the peripartum period remain poorly understood, limiting comprehensive insight into their pathophysiology. This study aimed to evaluate changes in neuroendocrine, angiogenic, and inflammatory biomarkers before and after delivery in women with GH and to compare these profiles with those of normotensive controls. Methods: This prospective study included women with singleton vaginal deliveries, assigned to GH and control groups (n = 20 per group). Clinical data were collected, and blood samples (pre- and 2 hours post-delivery) were analyzed for chromogranin A (CgA), catestatin (CST), soluble fms-like tyrosine kinase-1 (sFlt-1), placental growth factor (PlGF), interleukin-6 (IL-6), and C-reactive protein (CRP). Peripartum changes were evaluated using rank-based repeated-measures analysis. Results: CgA concentrations decreased significantly after delivery in both groups (pTime < 0.001), with comparable peripartum kinetics (pGroup×Time = 0.718; median difference [MD]: 2.3 ng/mL; 95% confidence interval [CI]: –5.4 to 7.8). PlGF concentrations were significantly lower in the GH group (pGroup = 0.002) and declined after birth (pTime < 0.001), with a clinically meaningful trend toward a greater decline in the GH group (MD: 78 pg/mL; 95% CI: 30 to 220). IL-6 increased 10-fold after delivery (pTime < 0.001), with a comparable shift between groups (pGroup×Time = 0.456; MD: 6.9 pg/mL; 95% CI: –9.1 to 21.2). CRP concentrations increased after delivery (pTime < 0.001), with no difference in peripartum kinetics between groups (pGroup×Time = 0.257). Pre-delivery CgA and sFlt-1 were strongly correlated in the control group (rs = 0.636, p = 0.003). Sex-stratified analyses revealed significantly lower IL-6 concentrations in female fetuses within the control group (1.9 vs. 3.6 pg/mL; p = 0.037), and significantly lower PlGF concentrations in female fetuses within the GH group (73 vs. 153 pg/mL; p = 0.039). Conclusions: Our results align with established patterns for angiogenic and inflammatory markers, but these novel neuroendocrine findings require validation in larger groups. Incorporating neuroendocrine regulation into models of GH is a key area for future study. Study Registration: The study has been registered on https://zenodo.org/ (registration number: zenodo. 18958924; registration link: https://zenodo.org/records/18958924).